# Lineage Cell Therapeutics, Inc.: Form 8-K, filed May 1, 2025

- Company: [Lineage Cell Therapeutics, Inc.](/companies/lctx.md) (CIK 876343)
- Form: 8-K
- Filed: 2025-05-01
- Accepted by EDGAR: May 1, 2025, 09:09 ET
- Period: 2025-05-01
- Accession: 0000950170-25-061466
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/876343/000095017025061466/lctx-20250501.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/876343/000095017025061466/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/876343/000095017025061466/lctx-20250501.htm

Filed May 1, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-061466. Last ingested by Listed: Oct 24, 2026, 14:58 ET. No prices; not investment advice.